发明名称 |
COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS HCV |
摘要 |
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of interferon, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof. |
申请公布号 |
HK1213191(A1) |
申请公布日期 |
2016.06.30 |
申请号 |
HK20160101220 |
申请日期 |
2016.02.02 |
申请人 |
AbbVie Inc. |
发明人 |
BERNSTEIN, Barry M.;DUTTA, Sandeep;LIU, Wei;PODSADECKI, Thomas J.;CAMPBELL, Andrew L.;MENON, Rajeev M.;LIN, Chih-Wei;WANG, Tianli;AWNI, Walid M. |
分类号 |
A61K;A61P |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|